WORLD JOURNAL OF PLASTIC SURGERY
Fri, Apr 19, 2024
[Archive]
Volume 10, Issue 3 (2021)
WJPS 2021, 10(3): 99-103 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Farokhforghani S, Fatemi M J, Ghanooni P, Asadpour F, Araghi S, Nouri A. Epidermolysis Bullosa Registry Data in Iran. WJPS 2021; 10 (3) :99-103
URL: http://wjps.ir/article-1-818-en.html
URL: http://wjps.ir/article-1-818-en.html
Siamak Farokhforghani 
1, Mohammad Javad Fatemi1 , Parinaz Ghanooni1 , Faraz Asadpour1 , Shirin Araghi2 , Afshin Nouri2
1, Mohammad Javad Fatemi1 , Parinaz Ghanooni1 , Faraz Asadpour1 , Shirin Araghi2 , Afshin Nouri2
1- 1- Burn Research Center, Iran University of Medical Sciences, Tehran, Iran.
2- 2- Hazrat Fatemeh Hospital, Iran University of Medical Sciences, Tehran, Iran.
2- 2- Hazrat Fatemeh Hospital, Iran University of Medical Sciences, Tehran, Iran.
Abstract: (2615 Views)
ABSTRACT
BACKGROUND
In many countries, there is no registry system to record data for Epidermolysis Bullosa patients. However, the first steps for establishing a registry system have been taken in Iran. Therefore, we decided to publish it for the first time.
METHODS
This was a prospective cross-sectional study. Data was obtained from 538 patients consecutively enrolled in the Iranian Epidermolysis Bullosa Registry, using a detailed instrument created by burn research center of Iran University of Medical Sciences, Tehran, Iran from Jan 2017 to Sep 2017. Patients’ information such as age, gender, address, educational status, parents’ family relationship and pathology result were recorded. Then a physician examined patients focusing on gastrointestinal system, teeth, ophthalmologic disorders, psychological problems and contracture of the upper and lower limbs and any other complaint. Data entered SPSS ver.19 and analyzed using ANOVA and LSD tests.
RESULTS
Overall, 538 EB patients were registered in Iran (6.72 patient in 100.000 person) with an approximately equal ratio between males and females. Among 103 patients whose disease type was determined by a pathologist, 78 patients (75.7%) had dystrophic type, 13 (12.6%) junctional, 9 (8.7%) simplex and 3 (2.9%) kindler type. The most common complaint of patients was dysphagia followed by tooth damage.
CONCLUSION
We stablished a data registry for EB patients for the first time in Iran. The frequency of EB in Iran is less than many other countries. However, data completion is to be done to include all patients as possible.
BACKGROUND
In many countries, there is no registry system to record data for Epidermolysis Bullosa patients. However, the first steps for establishing a registry system have been taken in Iran. Therefore, we decided to publish it for the first time.
METHODS
This was a prospective cross-sectional study. Data was obtained from 538 patients consecutively enrolled in the Iranian Epidermolysis Bullosa Registry, using a detailed instrument created by burn research center of Iran University of Medical Sciences, Tehran, Iran from Jan 2017 to Sep 2017. Patients’ information such as age, gender, address, educational status, parents’ family relationship and pathology result were recorded. Then a physician examined patients focusing on gastrointestinal system, teeth, ophthalmologic disorders, psychological problems and contracture of the upper and lower limbs and any other complaint. Data entered SPSS ver.19 and analyzed using ANOVA and LSD tests.
RESULTS
Overall, 538 EB patients were registered in Iran (6.72 patient in 100.000 person) with an approximately equal ratio between males and females. Among 103 patients whose disease type was determined by a pathologist, 78 patients (75.7%) had dystrophic type, 13 (12.6%) junctional, 9 (8.7%) simplex and 3 (2.9%) kindler type. The most common complaint of patients was dysphagia followed by tooth damage.
CONCLUSION
We stablished a data registry for EB patients for the first time in Iran. The frequency of EB in Iran is less than many other countries. However, data completion is to be done to include all patients as possible.
References
1. Has C, Bauer J, Bodemer C, Bolling M, Bruckner‐Tuderman L, Diem A, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol 2020;183(4):614-27. [DOI:10.1111/bjd.18921]
2. Has C, Liu L, Bolling M, Charlesworth A, El Hachem M, Escámez M, et al. Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa. Br J Dermato 2020;182(3):574. [DOI:10.1111/bjd.18128]
3. Has C, Nyström A, Saeidian AH, Bruckner-Tuderman L, Uitto J. Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone. Matrix Bio 2018;71:313-29. [DOI:10.1016/j.matbio.2018.04.001]
4. Uitto J, Has C, Vahidnezhad H, Youssefian L, Bruckner-Tuderman L. Molecular pathology of the basement membrane zone in heritable blistering diseases:: The paradigm of epidermolysis bullosa. Matrix Biol 2017;57:76-85. [DOI:10.1016/j.matbio.2016.07.009]
5. Kristensen MH, Schmidt SAJ, Kibsgaard L, Mogensen M, Sommerlund M, Koppelhus U. Validity of first-time diagnoses of congenital epidermolysis bullosa in the Danish National Patient Registry and the Danish Pathology Registry.Clin Epidemiol 2019;11:115. [DOI:10.2147/CLEP.S184742]
6. Bardhan A, Bruckner-Tuderman L, Chapple IL, Fine J-D, Harper N, Has C, et al. Epidermolysis bullosa. Nat Rev Dis Primers 2020;6(1):1-27. [DOI:10.1038/s41572-020-0210-0]
7. Chernyshov P, Suru A, Gedeon I, Derevyanko L, Tiplica G, Salavastru C. Epidermolysis bullosa‐specific module of the Infants and Toddlers Dermatology Quality of Life (InToDermQoL) questionnaire. J Eur Acad Dermatol Venereol 2019;33(3):612-7. [DOI:10.1111/jdv.15337]
8. Hammersen J, Has C, Naumann-Bartsch N, Stachel D, Kiritsi D, Söder S, et al. Genotype, clinical course, and therapeutic decision making in 76 infants with severe generalized junctional epidermolysis bullosa. J Invest Dermatol 2016;136(11):2150-7. [DOI:10.1016/j.jid.2016.06.609]
9. Aushev M, Koller U, Mussolino C, Cathomen T, Reichelt J. Traceless targeting and isolation of gene-edited immortalized keratinocytes from epidermolysis bullosa simplex patients. Mol Ther Methods Clin Dev 2017;6:112-23. [DOI:10.1016/j.omtm.2017.06.008]
10. Hainzl S, Peking P, Kocher T, Murauer EM, Larcher F, Del Rio M, et al. COL7A1 editing via CRISPR/Cas9 in recessive dystrophic epidermolysis bullosa. Mol Ther 2017;25(11):2573-84. [DOI:10.1016/j.ymthe.2017.07.005]
11. Koga H, Prost-Squarcioni C, Iwata H, Jonkman MF, Ludwig RJ, Bieber K. Epidermolysis bullosa acquisita: the 2019 update. Front Med 2019;5:362. [DOI:10.3389/fmed.2018.00362]
12. Fine J-D. Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry. JAMA Dermatol 2016;152(11):1231-8. [DOI:10.1001/jamadermatol.2016.2473]
13. Uitto J. Toward treatment and cure of epidermolysis bullosa. Proc Natl Acad Sci U S A 2019;116(52):26147-9. [DOI:10.1073/pnas.1919347117]
14. Fine J-D. Inherited epidermolysis bullosa. Orphanet J Rare Dis 2010;5(1):1-17. [DOI:10.1186/1750-1172-5-12]
15. Tadini G, Gualandri L, Colombi M. The Italian registry of hereditary epidermolysis bullosa. 2005.
16. Dănescu S, Has C, Senila S, Ungureanu L, Cosgarea R. Epidemiology of inherited epidermolysis bullosa in Romania and genotype-phenotype correlations in patients with dystrophic epidermolysis bullosa. J Eur Acad Dermatol Venereol 2015;29(5):899-903. [DOI:10.1111/jdv.12709]
17. Horn H, Priestley G, Eady R, Tidman M. The prevalence of epidermolysis bullosa in Scotland. Br J Dermatol 1997;136(4):560-4. [DOI:10.1111/j.1365-2133.1997.tb02141.x]
18. Yenamandra VK, Vellarikkal SK, Chowdhury MR, Jayarajan R, Verma A, Scaria V, et al. Genotype-Phenotype Correlations of Dystrophic Epidermolysis Bullosa in India: Experience from a Tertiary Care Centre. Acta Derm Venereol 2018;98(9-10):873-9. [DOI:10.2340/00015555-2929]
19. Ahmad RCS, Bruckner AL. A survey of epidermolysis bullosa care in the United States and Canada. Pediatr Dermatol 2014;31(2):169-75. [DOI:10.1111/pde.12258]
20. Kho YC, Rhodes LM, Robertson SJ, Su J, Varigos G, Robertson I, et al. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Arch Dermatol 2010;146(6):635-40. [DOI:10.1001/archdermatol.2010.109]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
